Key Data You Should Know Before Trading United Therapeutics Corporation (UTHR)

Facebook
Twitter
WhatsApp

United Therapeutics Corporation (UTHR) has seen some recent activity in the market and its common shares closed trading at $130.25 yesterday. Investors are starting to take notice of UTHR as the common shares traded as high as $133.67 and as low as $128.24 in the last market session.

United Therapeutics Corporation (UTHR) average trading volume is 346.72K. However, in the last market session United Therapeutics Corporation (UTHR) traded 934,594 shares. The 1st downside support level on UTHR is $126.89. UTHR 50-day moving average is $109.10 and UTHR 200 day moving average is $112.29.

United Therapeutics Corporation (UTHR) most recent performance has been indicated by the recent movement in UTHR common shares. UTHR has performed 28.96% over the past 30 days, UTHR has performed 16.85% over the past quarter and UTHR has shown 43.15% over the past 365 days. United Therapeutics Corporation (UTHR) has a 12 month range of $75.58 to $133.67. United Therapeutics Corporation (UTHR) is trading 72.33% from its 12 month low and -2.06% from its 12 month high. United Therapeutics Corporation (UTHR) is displaying a 4.67% short float displaying the quantity short in the float.

UTHR has 44.10M shares outstanding and 43.63M shares in the float. United Therapeutics Corporation (UTHR) at this time has a market cap of $5.75B and income of 429.80M. The EPS next quarter for UTHR is 2.82 and projected EPS next year is -4.75%. The market cap of United Therapeutics Corporation (UTHR) at $5.75B represents how many Investors own shares of UTHR and is calculated off the last price ($130.25) of UTHR and the quantity of shares outstanding (44.10M) with United Therapeutics Corporation (UTHR).

United Therapeutics Corporation (UTHR) has aggregate cash (mrq) of 1.56B, aggregate cash per share (mrq) of 35.14, aggregate debt of UTHR is at 800M and aggregate debt/equity (mrq) is 25.86. . United Therapeutics Corporation (UTHR) operational cash flow (ttm) is 666.5M, UTHR leveraged free cash flow (ttm) is 505.88M.

UTHR is trading 15.50% above (bullish) its SMA20, 20.96% above (bullish) its SMA50 and 21.31% above (bullish) its SMA200.

Related Articles

iHeartMedia (NASDAQ: IHRT) Announces Partnership With Podimo

iHeartMedia, Inc. (NASDAQ: IHRT) has entered into a partnership with Podimo, a European Podcast platform. Both the companies inked an agreement to adapt and...

Ruhnn (NASDAQ: RUHN) Receives Going Private Proposal

Ruhnn Holding Limited's (NASDAQ: RUHN) boards of directors have got the preliminary non-binding offer letter from three founders of the firm. Founder Chao Shen,...

Moderna (NASDAQ: MRNA) Inks 160M COVID Vaccine Doses Supply Deal With EU

Moderna, Inc. (NASDAQ: MRNA) has secured a supply contract for up to 160 million doses of COVID-19 vaccine candidates from the European Union. Moderna...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

iHeartMedia (NASDAQ: IHRT) Announces Partnership With Podimo

iHeartMedia, Inc. (NASDAQ: IHRT) has entered into a partnership with Podimo, a European Podcast platform. Both the companies inked an agreement to adapt and...

Ruhnn (NASDAQ: RUHN) Receives Going Private Proposal

Ruhnn Holding Limited's (NASDAQ: RUHN) boards of directors have got the preliminary non-binding offer letter from three founders of the firm. Founder Chao Shen,...

Moderna (NASDAQ: MRNA) Inks 160M COVID Vaccine Doses Supply Deal With EU

Moderna, Inc. (NASDAQ: MRNA) has secured a supply contract for up to 160 million doses of COVID-19 vaccine candidates from the European Union. Moderna...

Why Ayro (NASDAQ: AYRO) Stock Is Crashing Today?

Shares of Ayro Inc. (NASDAQ: AYRO) plummeted by 23.49% during the trading session on Tuesday. The firm has disclosed that it has completed the...

Amazon (NASDAQ: AMZN) Join Hands With Federal Watchdog To Stop Counterfeits

Amazon.com, Inc. (NASDAQ: AMZN) has disclosed today that it has teamed up with the National Intellectual Property Rights Coordination Center (IPR Center), a counterfeit...